Actemra Infusion - NPS MedicineWise
Figure 5 | The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
Frontiers | Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)? | Medicine
Actemra (Tocilizumab) Shortage Is Still Affecting Rheumatology Patients
How is Actemra® (tocilizumab) for GCA believed to work?
Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
Immunomodulation as a potent COVID-19 pharmacotherapy | JIR
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease - ScienceDirect
Tocilizumab-Atlizumab Overview - Creative Biolabs
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia | SpringerLink
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19 - ScienceDirect
JCI - IL-6 polymorphisms: a useful genetic tool for inflammation research?
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) - Clinical Microbiology and Infection
Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis | Infectious Diseases of Poverty | Full Text
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
